Results 111 to 120 of about 54,698 (143)

A propósito de mesotelioma pleural

Acta Médica Costarricense, 2006
Carlos Salazar Vargas
doaj   +2 more sources

La reutilización de biomarcadores para otros fines: oportunidades y dificultades en el cambiante campo de la medicina de laboratorio. [PDF]

Adv Lab Med
Gruson D, Menghoun N, Pouleur AC, Bayes Genis A.   +3 more
europepmc   +1 more source

Position Paper on Asbestos of the Italian Society of Occupational Medicine. [PDF]

Med Lav, 2019
Apostoli P, Boffetta P, Bovenzi M, Cocco PL, Consonni D, Cristaudo A, Discalzi G, Farioli A, Manno M, Mattioli S, Pira E, Soleo L, Taino G, Violante FS, Zocchetti C.   +14 more
europepmc   +1 more source

Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer. [PDF]

Mol Oncol
Rigon M, Mutti L, Campanella M.
europepmc   +1 more source

Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy. [PDF]

Front Oncol, 2021
Andretta E, Costa C, Longobardi C, Damiano S, Giordano A, Pagnini F, Montagnaro S, Quintiliani M, Lauritano C, Ciarcia R.   +9 more
europepmc   +1 more source

[Regulation and ban of asbestos in Latin America and the Caribbean: a comparative policy analysis]. [PDF]

Rev Salud Publica (Bogota)
Escobar-Díaz FA, Orozco-Castaño CA.
europepmc   +1 more source

A comprehensive multidisciplinary approach for identifying asbestos exposure among underground workers. [PDF]

Rev Bras Med Trab
Salvado A, Capone L, Zamorano P, Samudio M, Garcia-de-Dávila MT, Ernst G.   +5 more
europepmc   +1 more source

SMO mutations confer poor prognosis in malignant pleural mesothelioma. [PDF]

Transl Lung Cancer Res, 2020
Signorelli D, Proto C, Botta L, Trama A, Tiseo M, Pasello G, Lo Russo G, Fabbri A, Imbimbo M, Busico A, Prelaj A, Ferrara R, Galli G, De Toma A, Tamborini E, Pastorino U, de Braud F, Gatta G, Garassino MC, Ganzinelli M.   +19 more
europepmc   +1 more source

Retrospective analysis of predictive factors for epithelial-mesenchymal histological discordance following neoadjuvant chemotherapy in pleural mesothelioma

reservedScopo dello Studio: Scopo del nostro studio retrospettivo monocentrico è di individuare possibili fattori clinici e radiologici predittivi di una discordanza istologica epitelio-mesenchimale dopo trattamento chemioterapico ad intento ...
ZAMBELLO, GIOVANNI
core  

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. [PDF]

Int J Mol Sci, 2019
Guazzelli A, Meysami P, Bakker E, Demonacos C, Giordano A, Krstic-Demonacos M, Mutti L.   +6 more
europepmc   +1 more source